Morgan Stanley
-
-
-
-
-
-
-
Sarepta Therapeutics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) PPMO Hold Lift a 'Positive' - Morgan Stanley
-
-
-
-
-
-
-
Sarepta Therapeutic (SRPT) Stock Dips 6% on $500 Million Stock Offering
-
-
-
-
-
-
-
Regenxbio (RGNX) Files 'Unique' Lawsit Against Sarepta (SRPT), Saying Some Manufacturing Activities are Not Covered by Safe Harbor - Morgan Stanley
-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) Is Pulling Away From Pfizer, PT to $220 At Morgan Stanley
-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) PT Raised to $169 at Morgan Stanley
-
-
-
-
-
-
-
Morgan Stanley Downgrades Sarepta Therapeutics (SRPT) to Equalweight
-
211,042 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

